Hepatitis Forums
Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on March 13, 2017, 10:10:58 am
-
People undergoing nucleoside analogue treatment for hepatitis B virus (HBV) are less likely to see improvement in liver fibrosis (scarring) if they are overweight.
Publishing their findings in Alimentary Pharmacology & Therapeutics, researchers recruited 123 people with severe liver fibrosis who were receiving nucleoside analogue treatment for hep B through a clinic in Hong Kong and had previously had their fibrosis tested. The recruitment took place between December 2014 and December 2015.
Read more...
https://www.hepmag.com/article/overweight-hinders-liver-healing-hepatitis-b-treatment